ARCHIVES

NCAB Subcommittee Works On Drafting Quantitative Risk Assessment Policy

This article is from The Cancer Letter archive.

Vol. 08 No. 38 | October 1, 1982

Download PDF Visit The Full Archive

Related Articles

House Committee Seeks Information on ImClone Insider Stock Trading.

March 29, 2002

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Phase II Study Shows Positive Results in Reducing Dry Mouth

October 25, 2013

Antigenics Begins Phase II Trial Of Oncophage for NHL.

March 31, 2000

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

Also AACI honors MIT’s Robert Weinberg. Bernard Fisher wins two awards.

November 21, 2003